FDA Approves First Nucleic Acid Test To Screen For Additional Types Of HIV In Donated Blood And Tissue

Main Category: HIV / AIDS
Also Included In: Blood / Hematology;  Regulatory Affairs / Drug Approvals
Article Date: 07 Jan 2009 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  


Current Article Ratings:

Patient / Public:5 stars

5 (1 votes)

Healthcare Prof:5 stars

5 (2 votes)


The U.S. Food and Drug Administration approved the cobas TaqScreen MPX Test, the first nucleic acid test that screens for the presence of two divergent types of HIV in donated blood plasma and tissue.

"With the MPX test, blood donor testing laboratories will be able to use nucleic acid technology to screen for additional HIV strains, further assuring that donated blood and tissue are free from infection and providing better protection for patients," said Jesse L. Goodman, M.D., M.P.H., director of the FDA's Center for Biologics Evaluation and Research.

Nucleic acid is the common name for the large chemical compounds that make up the genetic material in living cells. The new FDA-approved test detects nucleic acid from HIV-2 and from HIV-1 Group O. HIV-2 infections and HIV-1 Group O infections are predominantly found on the African continent. Some cases of infection with these two types of viruses have also been detected in the United States.

In addition to HIV-2 and HIV-1 Group O, the MPX test simultaneously detects nucleic acid from the most common form of HIV, HIV-1 Group M, as well as the Hepatitis C Virus and the Hepatitis B Virus.

The MPX test is designed for use with plasma specimens from human donors of whole blood and blood components, but not for testing donated source plasma. Donated source plasma is considered plasma intended for further manufacturing.

The test is also intended for screening tissue specimens obtained while the donor's heart is still beating; it is not intended for use on specimens from donors whose heart no longer functions.

The cobas TaqScreen MPX Test runs on the fully-automated cobas s 201 System. It is manufactured by Roche Molecular Systems Inc., Pleasanton, Calif.

U.S. Food and Drug Administration

Article adapted by Medical News Today from original press release.
Visit our hiv / aids section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
U.S. Food and Drug Administration. "FDA Approves First Nucleic Acid Test To Screen For Additional Types Of HIV In Donated Blood And Tissue." Medical News Today. MediLexicon, Intl., 7 Jan. 2009. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/134473.php>

APA
U.S. Food and Drug Administration. (2009, January 7). "FDA Approves First Nucleic Acid Test To Screen For Additional Types Of HIV In Donated Blood And Tissue." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/134473.php.

Please note: If no author information is provided, the source is cited instead.




HIV / AIDS

Most Popular Articles



Follow Our HIV News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our HIV / AIDS Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »